ArticleFrontiers in pediatrics2023

Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia.

Wenxiu Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.